← All Sponsors
SPONSOR

Tcelltech Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: High-grade GliomaWHO Grade Ⅳ Glioma
NCT06482905 Phase 1
Recruiting

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

High-grade Glioma
United States, China View Trial →